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Abstract: Drug carriers with intelligent functions are 
powerful therapeutic and diagnostic platforms in curing 
various diseases such as malignant neoplasms. These 
functions include the remote noninvasive activation of 
drug using physical impacts, e.g. light exposure. Combi-
nation of different therapeutic modalities (chemotherapy, 
photodynamic therapy, and so forth) with light-responsive 
carriers enables promising synergetic effect in tumour 
treatment. The main goal of this review article is to pro-
vide the state of the art on light-sensitive delivery sys-
tems with the identification of future directions and their 
implementation in tumour treatment. In particular, this 
article reviews the general information on the physical 
and chemical fundamental mechanisms of interaction 
between light and carrier systems (e.g. plasmonic and die-
lectric nanoparticles), the design of optically responsive 
drug carriers (plain and composite), and the mechanisms 
of light-driven controlled release of bioactive compounds 
in biological environment. The special focus is dedicated 
to the most recent advances in optically responsive bioin-
spired drug vehicles.
Keywords: light-responsive drug carriers; release 
mechanisms; plasmonic nanoparticles; resonant 
dielectric nanoparticles; biomedical applications; tumour 
treatment.
1   Introduction
Drug delivery systems are designed to enable more effec-
tive drug administration, particularly, to deliver drugs to 
specific organs, to provide sufficient drug pharmacoki-
netics, and to improve solubility of drugs. Particulate 
delivery systems composed of organic and/or inorganic 
materials have proven their efficiency as drug carri-
ers with different release mechanisms. Controlled drug 
release upon external and internal stimuli is one of the 
most important properties of drug carriers such as nano-
particles (NPs) of organic or inorganic nature, as well as 
bioinspired delivery platforms. Typically, the drug activa-
tion occurs in response to environmental triggering, for 
example, changes in pH [1] and ionic strength [2] (chemi-
cal stimuli), temperature [3] (physical stimulus), enzy-
matic degradation [4] (biological stimulus), and others 
[5]. However, researchers and medical professionals have 
aspired to focus on mechanisms for noninvasive drug 
activation using physical stimuli. Regarding the imple-
mentation of physical approaches for drug release: ultra-
sound [6], light [7], and magnetic field [8] can be used. 
Light is the most biocompatible external impact that is 
widely used to activate drug carriers and induce the cargo 
release [9]. Therefore, penetration depth of light is an 
important parameter for an effective noninvasive drug 
activation. Penetration of light irradiation with the wave-
lengths less than 700 nm [ultraviolet (UV) and visible] is 
rather limited to 1 mm due to the scattering and absorp-
tion from skin layers [10]. Application of the near-infrared 
(NIR) light irradiation (700–1000 nm) to trigger release of 
the bioactive molecules (drugs) inside biological objects 
allows to overcome this penetration barrier due to the 
lowest absorption coefficients of hemoglobin, lipids, and 
water in the NIR region [10].
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There are two common mechanisms of light activation 
of bioactive compounds from the carriers: thermal effects 
and photochemical triggering (reassembly of organic 
carrier-structure upon light irradiation, which includes 
hydrophobicity–hydrophilicity transition or photocleav-
age reaction). Photothermally responsive drug carriers are 
able to adsorb light energy and convert it into heat. This 
heat further stimulates intracellular drug release from the 
carrier either by phase change mechanisms or by disrup-
tion of its structure. High temperatures (hyperthermia) 
also can reduce the cell viability; therefore, photothermal 
therapy (PTT) can be applied for such carriers along with 
the chemotherapy.
Another photoinduced mechanism involves either 
disruption of the hydrophobic–hydrophilic formulations 
with embedded photochromic moieties (e.g. micelles, 
liposomes [11]) or disassembly of the organic delivery plat-
forms due to photocleavage reactions [12]. It is worth high-
lighting that the photochemical oxidation reaction is a 
special case of photocleavage mechanisms of drug release 
as reported by Bédard et al. [13]. Based on the design of 
light-responsive drug carriers, their interaction with light 
can vary, which in turn involves different mechanisms 
of drug activation. The photorelease profiles of bioactive 
compounds from light-sensitive drug carriers can be regu-
lated via the adjustment of a number of parameters, such 
as light wavelength, light power intensity, duration of light 
exposure, and beam diameter [14, 15]. The important issue 
that should be taken into account is the stability of drug 
carriers in biological fluids. It is worth mentioning that 
after the first introduction of particulate drug carriers into 
biological fluids, organic compounds from these fluids 
tend to bind carriers’ surface forming so-called protein 
corona [16]. This protein coating may undergo continu-
ous adsorption and desorption, depending on the affin-
ity of the surrounding proteins to the carrier’s surface [17]. 
Protein corona can significantly change physicochemical 
properties of the carriers [18]. Moreover, it can affect par-
ticles light sensitivity [19]. For example, aggregated gold 
(Au) NPs can seriously induce the shift of plasmon band 
and therefore the efficiency of the light absorption [20].
For the design of light-responsive drug carries, various 
types of nanostructured materials based on plasmonic/
dielectric NPs [Au, silver (Ag), Fe2O3, Fe3O4, and others], 
photosensitizers (PSs), photochromic moieties [azoben-
zene (AZO), coumarin, spiropyran (SP), o-nitrobenzyl 
(NB), 4-bromo-7-hydroxycoumarin, and 2-diazo-1,2-naph-
thoquinone (DNQ)] have been considered. In addition, 
composite materials have gained interest as light-respon-
sive components because they combine the merits of 
organic and inorganic components. As an example, 
micelle-, liposome-, and polymer-based materials modi-
fied with light-responsive parts can be fabricated [21–23]. 
Moreover, the inspiration from the biological side leads 
to the development of the cell-based delivery systems 
possessing light-addressable properties. Development of 
such delivery platforms usually involves the application 
of therapeutically relevant cells that can be naturally 
recruited in the tumour regions and deploy drugs upon 
laser irradiation. Various cell types have been reported as 
effective natural carriers, including mammalian cells [red 
blood cells (RBCs), neutrophils, leukocytes, phagocytes, 
stem cells (SCs), B lymphocytes, T lymphocytes, natural 
killer (NK) cells], bacteria, and viruses [24].
This review article aims to underline most recent 
advances of research on the light-sensitive drug delivery 
platforms. Special focus is dedicated to the consideration 
of the fundamental physical and chemical mechanisms 
describing light–matter interactions, which stimulate 
either conformational or thermal changes in the struc-
ture of the drug carriers. It further summarizes recent 
progress on the existing plain (individual plasmonic/die-
lectric materials) and composite (inorganic/organic nano-
structured materials, as well as biomimetic platforms) 
drug delivery carriers, particularly on their design, drug 
loading/release possibilities, and biomedical applications 
(Figure 1).
2   Fundamental principles of light 
interaction with plasmonic and 
dielectric NPs
2.1   Physical aspects of NPs’ heating
Resonant particulate nanophotonic structures are proven 
to be effective tools for precise optical heating of various 
systems at the nanoscale. This heating can be achieved by 
interaction of light with such plasmonic (Au, Ag) and die-
lectric (Si, Ge) nanometer-scale particles differently [25–29]. 
Indeed, different optical resonances (plasmonic and Mie-
type resonance) of these NPs allow electromagnetic field 
localisation with further conversion to heat energy by dif-
ferent paths and efficiencies. Moreover, these resonances 
can be simply tuned to biological transparency region in 
the NIR optical range by varying their physicochemical 
parameters such as size, shape, and composition. This 
enables to precisely control the heating process at the depth 
of several centimeters inside a tissue. In this section, we 
consider these fundamental mechanisms of conversion of 
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light energy to heat in plasmonic and dielectric NPs focus-
ing on the nature of these processes and their dynamics.
2.1.1   Plasmonic heating
Photothermal therapy is one of the most remarkable 
examples of plasmonic heating application in biomedi-
cine. This heating is based on the nature of plasmonic 
NPs’ optical properties and arises from the resonant inter-
action of the electromagnetic field at certain frequencies 
with the oscillations of electrons (plasmons). These plas-
mons provide considerable enhancement of electric field 
near the NP surface as well as rise of optical absorption at 
the resonant frequency [20]. Generally, plasmonic heating 
can be described as the temperature accumulation and 
temperature distribution around the NP.
2.1.2   Temperature accumulation
As mentioned above, plasmonic NPs convert some part 
of this energy into heat under light irradiation, which is 
mainly related to absorption process. When considering 
the uniformly polarised spherical NP with the diameter, 
which is smaller than an excitation wavelength, this NP 
can be represented as an electromagnetic dipole (for larger 
spheres, Mie theory should be applied). In this case, the 
computation of the heat energy absorbed by plasmonic 
spherical NP strongly depends on the absorption cross-
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 is NP polarisability, k is the 
angular wave number in the medium, ε(ω) is a complex 
relative permittivity of plasmonic NP, and 2s snε =  is a real 
relative permittivity of a medium around the spherical NP 
with a radius of R.
The plasmonic resonance takes place at the frequency 
ω when ε(ω) ≈ − εS. In turn, the absorption cross-section is 
related with scattering and extinction cross-sections (σscat 
and σext) as follows [26]:
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Figure 1: Schematic overview of light-sensitive delivery systems, as well as drug release mechanisms.
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The power absorbed by the NP (Q) during irradiation 
is directly related with σabs and intensity of the incident 
light I as follows [25, 28]:
 abs
Q Iσ=  (3)
In case of complicated geometry, the power generated by 
the NP can be calculated through the heat power density 
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where E(r) is the electric field amplitude inside the NP, 
and ε0 is dielectric permittivity.
It is obvious that σabs plays an important role in the 
efficiency of conversion of light energy to heat. Table 1 
represents the estimated values of σabs for different plas-
monic materials, which can be used in PTT. Taking into 
account that Au is mostly nontoxic and biocompatible 
material [36], it allows to consider Au as the most suit-
able metal for plasmonic heating in nanomedicine. It is 
also important that the mechanisms of NP heating depend 
on laser modes, pulsed and continuous wave (CW). These 
processes are further discussed.
2.1.3   Temperature distribution around the NP
The good example illustrating the heating process of plas-
monic NP is described in the work [37], where a spheri-
cal Au NP with known radius (R) immersed in water and 
uniformly illuminated at a resonant frequency is studied. 
In this case, the initial increase in the instantaneous tem-
perature (moderate case) is considered; therefore, the 
changes in physicochemical properties of the material, 
mass transfer, cavitation, convection processes in liquid, 
oxidation of NP, possible molecular coatings, and others 
are not taken into account. Some of these examples can be 
found in several works [38–48].
It was established that the mode of laser irradiation 
(CW or pulsed) of plasmonic NP has a significant influ-
ence on the spatial extension of the temperature profile 
around the NP (Figure 2A), as well as temperature evo-
lution (Figure 2B) [28, 37]. This effect can be utilised to 
Table 1: Comparison of the absorption cross-section for different 
plasmonic NPs.
Diameter of NPs (nm) ωp (nm) σabs (nm2) Ref.
Au 10 532 ≈5.0 × 101 [30]
Ag 10 400 ≈0.5 × 103 [31]
Cu 10 310 ≈2.5 × 101 [32]
Au 50 532 ≈7.0 × 103 [33]
Ag 50 400 ≈1.8 × 104 [34]
Pt 90 420 ≈1.2 × 104 [35]
Au 90 532 ≈2.0 × 103 [33]
Figure 2: The modes of laser heating of Au NP in water.
(A) Spatial extension of the temperature profile in CW and pulsed modes of laser irradiation. The normalised time τ = t/τtr is used in case of 
pulsed irradiation. Insets, 3D representation of the temperature profile around plasmonic NP under CW and single fs-laser pulse irradiation. 
(B) Comparison of the time-dependent temperature behaviour for the CW (dashed line) and single-pulse illumination (solid line) modes. 
Reprinted with permission from [28, 37]. Copyright 2013 by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim; Copyright 2011 American 
Physical Society.
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control spatial region of heating and selectively start heat-
activated chemical processes.
In the CW mode of irradiation and spherical shape 
of the NP, the steady-state temperature distribution δT(r) 
outside the NP can be described as follows [28]:
 
( ) , NP
RT r T r R
r
δ δ= >  (5)
where δTNP is the uniform temperature increase of the NP; 
δT(r) ≈ δTNP when r < R.
In turn, for the nanostructures with axial symmetry 
(rods, ellipsoids, discs, and tori), the temperature increase 
can be set as follows [49]:
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where β is a dimensionless value introduced to correct 
geometry and equals 1 in case of sphere; Req is the equiva-
lent radius describing a sphere with the same volume as 
investigated for nonspherical NP; and κs is the thermal 
conductivity of the surrounding medium.
In the pulsed mode (picosecond and femtosecond 
scale), the interaction of laser radiation with a plasmonic 
NP can be generally described as step-by-step processes 
changing internal temperature of the NP and providing 
the temperature diffusion from heated NP to a surround-
ing media. These processes are schematically presented in 
Figure 3.
At first, the absorption of the laser energy by the free 
electron gas and its thermalisation (around 100 fs [37]) 
take place. At this stage, the temperature of the ions of 
the metal lattice Tp remains unchanged (nonequilibrium 
conditions). Then electron–phonon interaction starts 
and provides internal equilibrium in the NP volume with 
uniform temperature of the electron gas Te and metal 
lattice over a time scale of some units of ps (~1.7 ps in 
case of Au NP) [37]. At this point, the temperature of a sur-
rounding media Text is still lower compared to the heated 
NP’s temperature. The subsequent diffusion of heat from 
the NP to a media starts and lasts from the 10th of picosec-
onds to nanoseconds. To estimate the heat diffusion, the 













where L is the characteristic size of the NP (e.g. R for a 
sphere), and ρ and cp are the mass density of the NP and 
heat capacity at constant pressure, respectively.
It is worth mentioning that these processes are size-
dependent. For example, electron–phonon thermalisa-
tion does not depend on the size of NPs larger than 5 nm 
[37, 50] and can overlap in time with the electron–phonon 
thermalisation process for NPs smaller than 20 nm [37, 38].
The pulse repetition rate f and laser fluence F have an 
important impact on the heating process, and (3) can be 
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where I is average irradiance. In this case, the value of the 












where V is the volume of the NP.
It is important to note that the pulse repetition rate 
can be tuned to provide quasi-CW heating mode. In this 
case, heat will be delivered into the NP so fast that there 
will be no time for the NP cooling (f  1/τtr). Pulse duration 
and its ratio to τtr are other parameters, which have sig-
nificant influence on the heating/cooling dynamics in the 
pulsed mode [28]. When the small NP (less than 100 nm) 
is irradiated by the picosecond or femtosecond laser 
pulses, the interaction of the laser pulse with the NP can 
be observed in Figure 3, and the time of heating equals τtr 
(due to magnitude). Otherwise, under nanosecond pulses, 
the duration of heating is determined only by the duration 
of the laser pulse (the processes in Figure 3 time overlap) 
[28, 37].
Figure 3: Schematic representation of processes taking place under 
pulsed (~100 fs) laser irradiation of Au NPs.
The electronic temperature of the electronic gas (Te), temperature 
of the lattice (Tp), and surrounding media (Text), as well as room 
temperature (RT), are demonstrated on the scheme.
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An example of the different heating processes is 
shown in the recent work of Halas and coworkers, where 
authors experimentally revealed the variations in heating 
mechanisms under the investigation of light-triggered 
deoxyribonucleic acid (DNA) release from Au NPs [15]. 
Indeed, CW laser illumination drives the photothermal 
release of dehybridised single-stranded DNA, whereas 
femtosecond excitation results in negligible local heating 
followed by DNA release by breaking of the thiol bond. 
The authors underlined the importance of application of 
such NPs irradiated by different laser modes in the devel-
opment of NIR-triggered gene or drug delivery.
2.1.4   Heating of dielectric NPs
Another approach of the nanoscale heating is based on 
the utilisation of resonant NP made of high refractive 
index materials [26, 29, 51]. Initially, such NPs were not 
considered as effective heating tools. Indeed, metal NPs 
can provide high temperatures due to significant ohmic 
losses, which makes them very efficient for optically 
induced heating. The main drawback of heating in metal 
NPs is that this process is poorly controlled. Moreover, it 
can harm the nanostructure itself or/and lead to unde-
sirable chemical reactions in surrounding media [29]. In 
contrast, high-index (dielectric) materials possess low 
optical losses (no charged carriers) and therefore at the 
first sight cannot provide significant optically induced 
heating. However, recently it has been demonstrated that 
it is possible to achieve high light-to-heat conversion in 
these systems [26]. In particular, magnetic quadrupole 
resonances in silicon (Si) NPs have been employed to gen-
erate highly efficient optical heating.
To compare the heating process in a resonant NP 
(metal or dielectric), (3) can be introduced [26],
 
2
eff~Q F Vσ  (10)
where σ = ε0ωIm(ε) is electric conductivity, F = ⟨|E|2⟩/|E0|2 is 
spatially averaged field enhancement factor, and Veff is the 
effective mode volume inside the NP.
Therefore, these three components contribute to NP 
heating. Taking into account optical losses, the impact of 
the first two components (σF2) can be considered, includ-











In this case, the maximum value of σF2 can be 
achieved when γOhmic ≈ γrad [28]. This requirement is satis-
fied for small metallic and big dielectric NPs (Figure 4).
According to (10), the effective mode volume inside 
the NP Veff has also influence on the NP heating and can 
be calculated as follows [26]:
 
2
eff   plasmonic(  NP ,)V Dπ δ=  (11)
 ( )3eff /6 dielectric NP ,V Dπ≈  (12)
where δ is a skin depth (less than 20  nm in the visible 
range).
Thus, increase in the NP size for efficient optical-
induced heating is more reasonable in case of resonant 
dielectric NPs, which, at appropriate sizes, can provide 
comparable heating with plasmonic ones and sometimes 
even exceed it (Figure 5A).
Another interesting feature of dielectric materials is 
that many of them demonstrate Raman signal, which is 
Figure 4: Calculated resonant heating maps for a spherical NP with diameter D in the air for different real and imaginary parts of permittivity 
made for various ratios of wavelength λ to D.
In the calculations, λ is fixed, green lines depict dispersion for materials studied, and direction of arrows shows the wavelength increase (in 
micrometers). Reprinted with permission from [26]. Copyright 2017 American Chemical Society.
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not observed in plasmonic materials. This effect can be 
employed for developing the all-in-one system based on 
resonant dielectric NPs, which unifies optically induced 
heating with the thermometry at the nanoscale. Moreover, 
it has been demonstrated that resonant properties of such 
NPs can also be applied for the enhancement of Raman 
signal (e.g. 140 times at the magnetic dipole resonance in 
spherical Si NPs) [53].
The dependence of the Raman line shift Ω on dielec-
tric NP temperature can be considered on the example of 
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 A = −2.96  cm−1, 
B = −0.174 cm−1 for crystalline Si, and kB is the Boltzmann 
constant.
The plotted temperature dependence of Raman signal 
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Thus, the opportunity of the Raman nanothermom-
etry combined with the high temperatures, which can 
be achieved at optical resonances in dielectric NP under 
optically induced heating, makes them an attractive plat-
form for a wide range of applications [54–56]. The optical 
thermometry at the nanoscale available in these materials 
can be effectively used in the field of drug delivery to pre-
cisely control the temperature of drug release inside cell 
and avoid undesirable overheating. However, it is worth to 
mention that under high values of laser fluence or temper-
atures, thermo optical nonlinear effects can change refrac-
tive index and thermal conductivity of heated materials.
Compared to plasmonic NPs, the key difference of 
heating of dielectric NPs is the ability to heat them to higher 
temperatures up to 1000  K and more with less pumping 
laser intensity [52, 54]. This opens up the possibility of uti-
lisation of such NPs for drug delivery without phototoxicity 
[51], as well as for high-temperature photochemistry and 
catalysis at the nanometer scale. Indeed, Si quantum dots 
were proven to be effective nanosystems for applications in 
cell biology and medicine [57]. In turn, application of opti-
cally resonant high-refractive index nanoparticles (e.g. Si, 
Ge, Fe2O3, etc.) makes it possible to add another opportu-
nity related with optical-induced heating and control of 
chemical reactions in different systems at the nanoscale. 
For example, Zograf et al. employed resonant dielectric NPs 
to induce release of antitumour drug from biocompatible 
polymer microcontainers upon pulsed NIR-laser irradiation 
with less applied power density. Noninvasive intracellular 
release was probed on two cell types, carcinoma cells and 
SCs. The developed systems based on polymer containers 
decorated with dielectric resonant particles were found to 
have a high potential as drug delivery platforms [51].
2.2   Chemical aspects of light–NP interaction
The electron ejection from the metal surface by light, 
so-called photoelectric effect, was discovered by Hein-
rich Hertz [58] in 1887 during the study of the interaction 
between UV light and metals. Afterwards, Albert Einstein 
provided the explanation of this effect in 1905 by the fol-
lowing statement [59]: light consists of a set of photons 
Figure 5: Optically induced heating and thermometry in high-refractive index NPs.
(A) Comparison of temperatures achieved in plasmonic and dielectric NPs. The results of theory (solid lines) and experiment (circles) are 
represented. Heating conditions, λ = 633 nm, I0 = 2 mW/μm2. (B) Results of calculation of the temperature-dependent Raman shift on the 
temperature for Si NP from (13) (solid line) and its approximation (dotted line). Reprinted with permission from [26, 52]. Copyright 2017 
American Chemical Society; Copyright 2017 by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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with a discrete energy allowing electron ejection from a 
metal surface with a certain threshold, i.e. a minimum 
photon energy equals the metal’s work function. These 
discoveries induced the quantum revolution and stimu-
lated research in different fundamental directions, includ-
ing complex physical (discussed above) and chemical 
processes that can be excited by light.
In this section, we discuss the process of light–NP 
interaction from the chemical point of view. Figure 6 
illustrates photodissociation, decomposition, desorption, 
and quenching of chemical environment adsorbed to the 
surface of the NPs, as well as phototherapy. Interestingly, 
regardless of the metallic or dielectric nature of the NPs, 
these processes are the result of heating the NPs by light 
and light-induced transfer of charges or energy (Figure 6).
As discussed above, the light-induced heating of metal-
lic (plasmonic) and dielectric NPs includes different mech-
anisms and involves a cascade of complex processes [60]. 
In the former case, the excited plasmons can relax within 
tens of femtoseconds by nonradiative way and excite ener-
getic charge carriers (electrons and holes). Afterwards, the 
relaxation from non-Fermi to Fermi electron distribution 
occurs through electron–electron scattering. Cooling of 
this electronic gas takes picoseconds due to electron–pho-
non interaction with the following heat dissipation from 
the NP to surrounding media through phonon–phonon 
scattering. In case of dielectric NPs, after excitation of the 
charged carriers from the valence to conduction band, the 
relaxation of electrons occurs also through electron–pho-
non interaction with following heat dissipation from the 
NP surface. As a result, the energy transfer from photons to 
thermal energy of NP adsorbates (nuclear motion of atoms) 
takes from picoseconds to microseconds and activates the 
chemical bonds and chemical transformations with the 
following consequences.
2.2.1   Desorption (photons to thermal energy)
In some cases, the light-induced heating of the NPs with 
different adsorbates is applied for remote on-demand 
optical delivery/release of bioactive compounds with 
high spatial resolution [61]. Here we discuss the impor-
tant issues of desorption from the chemical point of view 
– the unbinding between adsorbates and NPs. It should be 
noted that desorption of organic compounds from the NP 
surface requires different energy depending on bonding. 
On the one hand, noncovalent bonding as hybridisation 
(hydrogen bonds, which, for example, results in forma-
tion of double-stranded DNA) [15] or electrostatic inter-
action (as an example, the interaction between cationic 
polymers and negatively charged single-stranded and 
double-stranded nucleic acids) requires a little (up to 
several meV) thermal or electronic energy for desorption 
[62]. This interaction is also important for protein corona 
formation around NPs [16, 54]. On the other hand, the 
covalent bonding is generally achieved by coupling with 
amino acid residues as -NH2, -SH, and -COOH. In the case 
of covalent bonding, the dissociation of the bonds as 
thiol group, amine-carboxylate coupling, and complex 
of azide-tagged NP and alkyne-tagged adsorbate [63] 
requires much higher energy at least 0.1 eV by heating or 
electronic injection [15, 62, 64].
2.2.2   Photodissociation and decomposition (photons to 
thermal energy)
The catalytic reactions such as ammonia synthesis, hydro-
carbon reforming, oxidation, hydrogenation, and others 
are generally triggered by heating at relatively high tem-
peratures (500°C or greater). This process involves the 
excitation of phonons of the NP and their coupling to 
vibrational modes of the adsorbates [65]. For instance, 
heating of Au NPs dispersed in water–ethanol mixture 
results in decomposition of ethanol to CO2, H2 and CO, 
whereas dicumyl peroxide can be decomposed by light on 
the surface of Au NP into 2-phenyl-2-propanol and aceto-
phenone [66, 67].
Figure 6: Schematic illustration of the light–NP interaction. 
(A) Local heating of NPs and adsorbates, (B) electron and/or hole 
transfer to adsorbates, and (C) energy transfer from/to NPs. These 
three mechanisms allow observing chemical transformation of 
surroundings including photodissociation, photodecomposition, 
photodesorption, and other. The green arrows represent the 
incoming light, while the red arrows correspond to electron 
relaxation with the loss of its energy and re-emission of the light. 
The heat distribution is represented as hemispheres.
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2.2.3   Phototherapy (photons to thermal energy)
The electron–phonon scattering in plasmonic NPs can 
result in significant heating to the melting temperature of 
NPs. As discussed, the tuning of the NP shape and size 
can shift the plasmon resonance to NIR range, where the 
light absorption of tissues is limited. In case of therapy 
with plasmonic NPs, the illumination results in local effi-
cient heating of these NPs with following cellular hyper-
thermia, cell death, and tumour remission, as well as 
treatment of epithelial carcinoma SK-BR-3, photothermal 
destruction of malignant squamous cell, and others [68–
70]. Moreover, owing to local heating, plasmonic NPs can 
be used for modulation of thermosensitive ion channels 
without cell damage [71, 72].
The photothermal mechanism described above 
assumes the energy conversion of photons to phonons of 
the NPs, which triggers the chemical transformation. An 
alternative mechanism involves the energy conversion 
of photons to energetic charge carriers. These carriers 
can transfer from the NP to adsorbate before their inter-
action with phonons and following energy dissipation. 
The efficiency of this process depends on overlapping 
of electronic states of the NPs and adsorbates as well as 
lifetime of exited carriers. In case of efficient excitation of 
charges, their spatial separation and following transfer to 
the adsorbates should occur. The injection of electrons or 
holes to adsorbates should be considered separately; nev-
ertheless, it results to the same effect mentioned above.
2.2.4   Desorption (photons to energetic charge carriers)
Similar to the desorption caused by light-induced heating 
and utilised for drug and gene delivery, the electron-
induced mechanism demonstrates less efficiency, but 
higher stability of the adsorbates. For example, pulsed 
laser radiation can break thiol Au-SH bonds by hot-elec-
tron transfer for double-stranded DNA release from the NP 
surface [15]. We omit here the detailed discussion, as this 
process is well described in [73], and the corresponding 
mechanism (desorption induced by electronic transition) 
is also discussed in previous works [65, 74, 75].
2.2.5   Photodissociation and decomposition (photons to 
energetic charge carriers)
In general, after electron and hole separation by light 
and before their collision, these energetic charges can be 
transferred to the adsorbates, which can result in differ-
ent effects. Energetic holes of the NPs serve as principal 
oxidants and are involved in different processes as gen-
eration of reactive hydroxyl radicals (OH·) [76, 77], water 
splitting (H2O + 2h+ → 2H+ + ½O2), and reactive oxygen 
species (ROS) (H2O + h+ → H+ + ·OH) [78–80], as well as oxi-
dation of citrate molecules and ethylene adsorbed on the 
NPs [81–83] and many others. In contrast, energetic (hot) 
electrons participate in hydrogen evolution (2H+ + 2e− → 
H2), generation of superoxide anion ·O2− [80], dissociation 
of oxygen to O2− ions [82], hydrogen dissociation, reduc-
tion of nitroaromatic compounds, ammonia decomposi-
tion (2NH3 → N2 + 3H2) [84], hydrogen production from 
ammonia borane, and esterification of benzaldehyde with 
alcohol to produce ethyl benzoate [74, 85–88]. Moreover, 
for the most complex systems such as Saccharomyces 
cerevisiae functionalised by indium phosphide NPs, the 
electron injection from the illuminated NPs to such heter-
otrophs stimulates cytosolic regeneration of redox cofac-
tor nicotinamide adenine dinucleotide phosphate [89], 
whereas the complex of Moorella thermoacetica–CdS NPs 
represent the electronic transfer from the NPs to bacteria 
for photosynthetic reduction of CO2 to produce acetic acid 
[90]. However, in case of dielectric NPs, such catalytic 
activity is limited due to the large band gaps (several eV) 
of common semiconductors as titanium dioxide (TiO2) and 
very low mobility of their charge carriers. Additionally, it 
should be noted that, in contrast to the heat-induced dis-
sociation and decomposition, where the NPs and adsorb-
ates are in thermal equilibrium, the charge-induced 
reaction allows exciting specific vibrational modes of the 
adsorbates, selectively increases its temperature, and trig-
gers specific reaction.
Finally, resonant interaction between light and the 
NPs can result in electromagnetic field localisation near 
the NP surface [91]. In this case, plasmonic NPs demo-
nstrate unprecedented values of field localisation on their 
surface or in the gaps, whereas dielectric NPs demonstrate 
the electromagnetic field localisation mostly inside their 
volume with slight dissipation of energy to their surface 
[52, 92]. In any case, the enhancement of electric field |E| 2 
on the surface increases the rate of electron–hole pairs for-
mation in adsorbates that stimulate their chemical trans-
formation [93] via the generation of singlet oxygen 1O2 on 
the surface of metallic and dielectric NPs [80]. Moreover, 
the energy transfer can be carried out both from the NP 
to adsorbates, and vice versa [62]. In the latter case, the 
energy transfer is described by NP surface energy trans-
fer mechanism [94], where an optically excited organic 
fluorophore acts as a donor, which transfers its energy 
by dipole–dipole interaction to acceptor (NPs) through a 
nonradiative path. The efficiency of this process directly 
depends on overlapping of donor emission spectrum and 
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acceptor absorbance. The distance between donor and 
acceptor [94] and the size of acceptor [95] also play a criti-
cal role in the energy transfer efficiency. 
3   Light-responsive plain delivery 
systems: recent applications in 
nanomedicine
3.1   Plain plasmonic NPs
As described above, plasmonic NPs (e.g. Au and Ag) 
have proven to show strong scattering and absorption of 
light in visible and NIR region owing to their localised 
surface plasmon resonances (SPRs). The absorbed light is 
then transformed into thermal energy [96]. Being a good 
nanoheaters, the Au and Ag NPs provide a versatile and 
multifaceted platform for a broad range of biomedical 
applications such as drug delivery.
3.1.1   Au NPs
Among various light-responsive delivery platforms, Au 
NPs have attracted tremendous interest as drug carriers 
due to their particular features; simple synthetic manipu-
lation; enabling precise control over the physicochemi-
cal properties of particles; and strong binding affinity to 
thiols, disulphides, and amines, which allow performing 
surface coating [97]. At present, various synthetic condi-
tions have been developed for the fabrication of aniso-
tropic Au NPs with different sizes and shapes. Based on 
dimensions, Au NPs can be divided into three categories: 
(i) one-dimensional Au NPs (e.g. nanorods, nanowires, 
nanotubes, etc.); (ii) two-dimensional Au NPs (e.g. stars, 
pentagons, squares/rectangles, dimpled nanoplates, hex-
agons, truncated triangles), and (iii) three-dimensional 
Au NPs (e.g. nanotadpoles, nanodumbbells, nanopods, 
nanostars, and nanodendrites). As mentioned above, the 
SPR band of Au NPs depends on the morphology (e.g. 
shape, size, core charge, etc.) of Au NPs. A variety of Au 
NPs with different morphologies and sizes were fabri-
cated to manipulate the visible and NIR spectrum. As an 
example, recently developed anisotropic popcorn-shaped 
Au NPs possessed tunable SPR, high colloidal stability, 
and high biocompatibility [98].
The effective SPR absorption of Au NPs allows employ-
ing these NPs in photodynamic therapy (PDT). Moreover, 
the modification of Au NPs with PSs allows enhancement 
of the PDT efficiency in cancer treatment. For instance, 
in the recent work, generation of singlet oxygen was 
effectively tuned by manipulating the physical location 
between Au NPs and PSs [99]. Usually, the synergy of Au 
NPs and PSs occurs in the following manner: the energy 
transferred from the Au NPs to the PSs enhances the pho-
todynamic effect with higher stability. After administra-
tion of Au NPs in vivo and reaching the tumour cells, ROS 
are released from the PSs attached to the surfaces of Au 
NPs under irradiation. The released ROS demonstrate 
phototoxic features, whereas nonphototoxic effects are 
usually observed in the blood circulation without expo-
sure to light. Thus, this synergy of plasmonic NPs with 
attached PSs demonstrates selectivity of the used therapy.
As mentioned above, the heating abilities of Au NPs 
make it possible to utilise them also in PTT. It was dem-
onstrated that the heat causes the death of malignant 
tumours [100]. In general, based on many reports, spheri-
cal solid Au NPs with diameter greater than 50 nm are the 
most commonly used platform in PTT. Recently, Au NPs 
were combined with other nanostructures. For example, 
Chen et  al. [101] combined Au NPs with NaYF4,Yb3+/Er3+ 
nanomaterials and coated the resulted structure with 
silica shell. The surfaces of these nanocomposites were 
then decorated with folic acid through multiple steps to 
impart the Au NPs properties of selectivity in vivo. The 
NaYF4,Yb3+/Er3+ nanostructures acted as light converters 
and emitted green and red light under 980 nm laser exci-
tation. The additional silica coating improved biocompat-
ibility of the developed systems. This system exhibited 
significantly enhanced therapeutic efficiency as demon-
strated in vitro and in vivo.
The Au NPs can be also employed as effective nanocar-
riers that are capable of carrying various drugs such as pep-
tides, proteins, plasmid DNAs, small interfering ribonucleic 
acids, and chemotherapeutic agents [97]. Various surface 
modification strategies of Au NPs were developed, which 
allow controlling the penetration and retention of NPs in 
tumours. For instance, polyethylene glycol (PEG) coating 
is one of the widely used methods for Au NP modification 
to prolong the blood circulation time of NPs and enhance 
their accumulation into tumour cells. Also, the surface of 
Au NPs can be modified with antibodies that allow per-
forming targeted delivery of drugs to the area of interest. 
This enables the combination of the targeted properties 
of Au NPs with the therapies (e.g. PDT, PTT). In the recent 
work, Au NPs were loaded with a variety of antitumour 
agents, including paclitaxel, methotrexate, daunorubicin, 
gemcitabine, platinum complexes, doxorubicin (DOX), etc. 
[102]. In this case, loading was performed by simple physi-
cal adsorption of antitumour agents on Au NPs or by using 
alkanethiol linkers. The successful loading of antitumour 
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drugs was probed both in vitro on tumour cell cultures and 
in vivo using mice bearing implanted tumours of various 
natures and localisations (Lewis lung carcinoma, pancre-
atic adenocarcinoma, and so forth) [102].
The light sensitivity of Au NPs allows controlling the 
release process of the drugs. In many works, the light 
stimuli were used to release drug molecules from Au NPs. 
For example, Sreejivungsa et  al. [103] developed a novel 
monolayer of Au NPs for the controlled release of a model 
drug using UV light. Wang and colleagues fabricated mul-
tifunctional Au NPs loaded with DOX for the treatment of 
metastatic breast cancer [104]. Upon laser irradiation, the 
local temperature of Au NPs was increased substantially 
and efficiently released DOX from the Au NP surface. In 
another work, Zhang and colleagues developed a core-shell 
NPs that consisted of Au nanoshell and 10-hydroxycamp-
tothecin for the treatment of breast cancer [105]. After the 
introduction of the developed NPs in vivo and their irradia-
tion at power density of 1 W cm−2 with the exposure time 
of 10 min, full tumour remission in a 4T1 breast syngeneic 
mouse model was observed. It is important that no sig-
nificant weight loss of mouse and tumour recurrence were 
indicated. Park and coworkers [106] designed PEGylated 
multifunctional hollow Au NPs for delivery of DOX against 
A549 lung cancer. Upon NIR irradiation, the Au NPs effi-
ciently released DOX. Furthermore, these NPs were capable 
of sensitising A549 cells to X-ray radiation. The effective 
combination of chemotherapy (DOX), PTT (high tempera-
ture), and radiation resulted in the highest cytotoxic effect 
of the developed systems. In another study, Si phthalocy-
anine 4 (a drug for the treatment of rabies) was linked to 
PEGylated Au NP conjugates. After reaching the tumour site 
and further passive accumulation of NPs, the molecules of 
phthalocyanine 4 were released from the surface of the NPs 
under irradiation with light at 670 nm [107]. Recently, Zhang 
et  al. [108] developed a new Au NP with immunological 
properties that possessed core-shell structure. These NPs 
could release heat (PTT) and tumour antigen-based immu-
notherapeutic agent. The obtained results clearly demon-
strated the accumulation of Au NPs in the tumour area, for 
example, in tumour-bearing mice in 24 h after administra-
tion (Figure 7B) and, therefore, improved antitumour effect 
from both PTT and immune therapy (Figure 7C).
When speaking about Au NPs, photoporation should 
be mentioned as a valuable approach to deliver various 
bioactive molecules in a controlled manner. The mecha-
nism of photoporation is based on the large absorption 
cross-section of Au NPs and their ability to raise temper-
ature upon irradiation. After incubation of Au NPs with 
cells, Au NPs absorbed onto cell membranes can permeabi-
lise membranes upon laser irradiation through thermally 
induced phenomena, local heating, acoustic waves, or 
formation of water vapour bubbles. Indeed, Xiong et  al. 
[109] used 70 nm Au NPs, which were adsorbed onto cell 
plasma membrane after 30  min. Afterwards, compound 
of interest was added, and cells were irradiated in a con-
trolled manner with laser in pulsed regime. The forma-
tion of vapour bubbles induced nanopores in cell plasma 
membrane and allowed compound of interest to diffuse 
inside cells. This approach enables selective delivery of 
bioactive molecules in a spatially resolved manner using 
Au NPs [109].
Overall, Au NPs are the most widely studied drug car-
riers because of low inherent toxicity, high surface area, 
and tunable stability. However, some issues still need to 
be addressed such as engineering of Au NP’s surface in 
order to improve Au NP’s bioavailability and immuno-
genicity. Moreover, Au NPs are not able to protect cargo 
from degradation in biological fluids, as bioactive com-
pounds are usually attached to the NP’s surface, and to 
keep these molecules intact, additional organic coatings 
are required.
3.1.2   Silver NPs
Silver NPs are also a widely studied plasmonic material 
that can be used in biomedical applications. An advantage 
of Ag NPs is simple and low-cost chemical synthesis. Silver 
NPs can be obtained in various shapes, such as spherical, 
rod, octagonal, triangle, flower-like, etc. As a drawback, 
Ag NPs have low biocompatibility and, therefore, cyto-
toxicity to healthy cells. The smaller-sized Ag NPs cause 
enhanced cytotoxic effects compared to the larger coun-
terparts due to the increased surface reactivity of NPs. The 
shape of Ag NPs also contributes to overall toxicity. As the 
size and shape of Ag NPs are directly related to the SPR, it 
is important to optimise the Ag NP morphology in order to 
achieve the sufficient biocompatibility and effective light 
sensitivity. As for Au NPs, the surface of Ag NPs can be 
coated with biopolymers, which can reduce their cytotox-
icity. By varying the size and shape, it is possible to tune 
the plasmon peak of Ag NPs in the range of 393–738 nm 
and 500–1000 nm, which leads to strong visible and NIR 
scattering and absorption enabling employment Ag NPs 
in PTT and PDT [110].
Similar to Au NPs, Ag NPs are also good nanoheaters, 
and this can be effectively employed in PTT. In the recent 
work, Ag-based NPs were developed with the improved 
ability to absorb NIR irradiation. The developed systems 
could perform PTT therapy against A549 cells at a low irra-
diation power density (0.20 W cm−2) without any damage 
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to the normal healthy cells and the surrounding tissues 
[111]. Another study reported that DOX-loaded Ag-based 
NPs demonstrated excellent chemophotothermal thera-
peutic efficiency and possessed NIR-laser–controlled 
drug-releasing functions [112].
Several researchers developed Ag NP-based PSs for 
PDT [113]. In general, to fabricate Ag NP-based PSs, bovine 
serum albumin (BSA) is used [113]. The functional groups 
of BSA (e.g. amino, imidazolyl, and thyol) interact with Ag 
ions forming stable Ag–BSA complexes. For example, Cui 
and colleagues synthesised Ag nanodots using BSA via 
biomineralisation method [114]. The diameter of Ag nano-
dots was 5.80 ± 0.5 nm, which corresponded to the most 
optimal photothermal properties. Later, Vankayala et al. 
Figure 7: In vivo characterisation and antitumour effect of immunological Au NPs combined PTT and tumour antigen-based immunotherapy.
(A) Schematic diagram of PTT using Au NPs. (B) In vivo distribution of Au NPs labeled with fluorescent marker in tumour-bearing mice at 
different time points. IR thermal images with corresponding temperature profiles. (C) The photographs of tumours from the sacrificed mice 
at the 21st day. Tumour growth curves after different treatments with and without laser irradiation of 2.0 W cm−2. Tumour weight of the 
sacrificed mice at the 21st day. Adapted with permission from [108]. Copyright 2019 American Chemical Society.
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[115] showed that singlet oxygen can be formed through 
direct sensitisation using Ag NPs without presence of any 
organic PSs under light irradiation.
Some studies reported that the fast biodegradation of 
Ag NPs on the cellular level and within a whole organism 
can significantly limit the application of Ag NPs for drug 
delivery applications. Motivated by the high plasmonic 
potential of Ag NPs, several strategies were suggested 
to preserve Ag nanostructure from the fast degradation 
[116]. These strategies mostly focus on surface modifica-
tion of Ag NPs with an extra protecting layer of inorganic 
or organic coating, such as Si [117], graphene oxide (GO) 
[118], self-assembled monolayers of organic thiols [119], 
etc. Another approach to protect the unstable Ag NPs 
involves Au coating. As discussed above, the Au NPs 
possess own plasmonic resonances in combination with 
slow biodegradation in the biological environment. The 
result of Ag modification with Au nanostructures can lead 
to the enhanced plasmonic properties. Up to now, there 
are only few studies employing Ag–Au NPs as light-sen-
sitive drug delivery carriers [120, 121]. Nevertheless, the 
PTT potential and fate in the biological environment of 
Ag-based NPs are not fully explored. Recently, Espinosa 
et al. [116] fabricated anisotropic hybrids composed of Ag 
NP cores coated with Au shell, which possessed efficient 
NIR absorption. For this synthesis, Au nanostars and Ag 
Figure 8: Structure and photothermal efficiency of Ag, Au, and Ag–Au NPs.
(A) Transmission electron microscopy (TEM) images and UV-visible/NIR spectra of Au NPs, Ag NPs, and Ag–Au NPs. (B) Infrared (IR) thermal 
images of mice injected with Ag NPs and Ag–Au NPs exposed under NIR-laser irradiation (680 nm, 1 min, 1 W cm−2) with corresponding 
analysis of average temperature after 1 min of 680 nm NIR-laser exposure and effect on tumours. Reprinted with permission from [116]. 
Copyright 2018 American Chemical Society.
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nanoplates were used (Figure 8A). The evaluation of the 
photothermal efficiency and intracellular biodegrada-
tion of the developed Ag–Au-based NPs was tested on the 
tissue-mimetic model in vivo. According to the obtained 
results, almost total tumour regression was observed on 
the example of mice model. Moreover, in the compara-
tive study, it was demonstrated that the cellular heating 
was much more efficient in case of Ag–Au NPs compared 
to individual Ag NPs. This indicated the high potential of 
Ag–Au NPs in PTT due to improved heating properties of 
the developed carriers (Figure 8B). Thus, the surface mod-
ification of Ag NPs by Au coating provides new functional 
properties for developing efficient drug delivery platform.
3.2   Plain dielectric NPs
Despite wide applicability of plasmonic NPs as light-sen-
sitive drug delivery carriers, Au and Ag NPs have finite 
conductivities at optical frequencies. This can lead to the 
inherent dissipation of the electromagnetic energy [122]. 
Moreover, fluorescent compounds placed near plasmonic 
NPs experience quenching effects. To overcome this, the 
additional spacer on plasmonic NP’s surface is needed to 
increase the distance between the fluorescent molecule 
and surface of NP [123]. Alternatively, the high refractive 
index dielectric NPs are under intensive investigation. 
Owing to their better resonant properties, dielectric NPs 
such as Si, Ge, and Fe2O3 can be more efficient heaters 
compared to plasmonic counterparts [26]. Therefore, reso-
nant dielectric NPs have a great potential to be used as 
drug delivery carriers, enabling remote controlled activa-
tion of drugs under optical irradiation.
3.2.1   Si NPs
One of the most abundant light-sensitive materials that 
can be also used in nanomedicine is Si. The most common 
approach to fabricate crystalline Si NPs is laser ablation, 
resulting in an effective nanoheater with excellent reso-
nant properties [26, 124]. Alternatively, electrochemical 
etching approach for the Si NP synthesis leads to the for-
mation of porous Si NPs, which can be effectively loaded 
with drugs. Xia et  al. [125] demonstrated an increased 
delivery of the commercially available drug DOX into 
cancer cells using light-sensitive porous Si NPs. These car-
riers were loaded with a transducer (indocyanine green), 
which can effectively convert light into heat. NIR irradia-
tion of the internalised carriers resulted in the increased 
release of DOX compared to the pH-induced release in 
the acidic microenvironment of lysosomes [125]. Another 
study reported on the excellent heat generation abilities of 
porous Si NPs under NIR irradiation itself enabling PTT. In 
vivo animal tests on the Balb/c mice revealed murine colon 
carcinoma (CT-26) tumours were completely resorbed 
within 5 days after porous Si NP treatment in combination 
with NIR laser [126]. Apart from PTT, porous Si NPs can 
provide efficient PDT, which involves the conversion of 
ground-state molecular oxygen (3O2) to singlet oxygen (1O2) 
by energy transfer. As mentioned, the 1O2 is highly reactive 
and can cause the lethal damage of target cells [127]. When 
excited with visible light, the quantum-confined domains 
in porous Si NPs generate 1O2, and due to extremely long 
exciton lifetime, 1O2 generation is efficient [128]. Indeed, 
Xiao et  al. [129] demonstrated an improved PDT from 
porous Si NPs prepared by electrochemically etched Si 
wafers in cancer cells (HeLa and NIH-3T3). According to 
the obtained data, 45% of cells were dead after PDT treat-
ment compared to the less than 10% cytotoxicity in control 
experiments [129]. Si NPs can be also used as carriers for 
the PSs that are designed to generate ROS. Secret et  al. 
[130] covalently linked porphyrin to the Si NPs in order to 
demonstrate imaging and PDT in vitro under two-photon 
excitation (TPE) conditions. The authors demonstrated 
that PDT occurred under TPE conditions, where Si NPs 
transferred light energy to porphyrin, resulting in MCF-7 
breast cancer cell death [130]. Other PSs can be used to 
modify Si NPs for PDT. Knežević et  al. [131] employed 
ruthenium (Ru) (II) complexes that can adsorb visible and 
UV to functionalise Si NPs. The surface of Si NPs was addi-
tionally linked with targeting moieties to enable selective 
targeting to tumour tissues. The developed systems dem-
onstrated increased cytotoxicity under exposure to blue 
and NIR light [131]. The fluorescent small-sized (4 nm) Si 
quantum dots (QDs) were also applied as PSs (chlorin e6) 
carriers for PDT. Additionally Si QDs were modified with 
MnO2, which is known to produce oxygen in the reaction 
with the endogenous excess metabolites (H2O2) in acidic 
tumour microenvironment. The developed Si-based carri-
ers enabled enhanced loading capacity with PSs and dual-
imaging properties [fluorescence and magnetic resonance 
tomography, magnetic resonance imaging (MRI)], which 
resulted in significant inhibition of HeLa-bearing tumour 
in vivo [132].
3.2.2   Titanium dioxide NPs
Another light-responsive material that can be used as drug 
delivery carriers is TiO2. An important feature of TiO2 NPs 
is its photocatalytic properties, which can be activated 
under visible or UV light. This results in generation of 
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cytotoxic ROS such as hydrogen peroxide and peroxy radi-
cals, which can be harmful for targeted cells [133]. Unlike 
Si NPs, TiO2 NPs are mostly synthesised using chemical 
methods, such as solvothermal method, sol–gel methods, 
and so forth [134]. This allows precise controlling size 
and shape of TiO2 NPs, which is essential in biomedical 
applications. Liu et al. [135] probed photocatalytic activity 
of TiO2 NPs, which were attached onto the surface of TiO2 
nanotubes in Streptococcus mutans and Porphyromonas 
gingivalis bacteria. The developed photosensitive material 
demonstrated improved antimicrobial properties under 
UV light due to decreased size of TiO2 NPs and therefore 
increased surface area and greater amount of released 
toxic ROS [135]. In another study, Yadav et al. [136] real-
ised the combined cancer therapy using coral-shaped 
TiO2 NPs loaded with anticancer drug DOX. The increased 
surface area of TiO2 NPs resulted in increased payload of 
DOX onto the NPs. The developed delivery systems pro-
vided synergetic cytotoxic effect in cancer MCF7 cells 
from the released DOX (under biological stimuli inside 
cells) and generation of ROS from the TiO2 NPs (under 
UV-light irradiation) [136]. From clinical perspective, the 
photoactivation of TiO2 NPs with UV light has several limi-
tations, such as low tissue penetration depth [137], and 
UV-mediated ROS production lasts for a short time and is 
not enough to provide a sustained and prolonged tumour 
destruction [138]. To address it, the drug delivery systems 
based on TiO2 NPs, which generate ROS under UV-light 
irradiation, can be loaded with visible light-responsive 
PSs. Indeed, TiO2 NPs were loaded with Ru complexes, 
which are already in clinical trials as anticancer agents 
[139]. Ruthenium complexes are able to generate 1O2 under 
visible light irradiation. The developed systems showed 
sensitivity to UV and visible (green) light as demonstrated 
in melanoma cells [140]. Another way to overcome the lim-
itation of UV light is represented by the X-ray–responsive 
mesoporous TiO2 NPs that can be also employed for PDT. 
In the recent study, Guo et al. [141] designed an effective 
drug delivery platform that possessed combined cancer 
therapy (PDT and chemotherapy) based on mesoporous 
TiO2 NPs. These carriers were loaded with anticancer drug 
DOX. Additionally, surface of mesoporous TiO2 NPs was 
modified with targeting moieties [hyaluronic acid (HA) 
and cyclic pentapeptide]. The developed systems demon-
strated an increased selectivity to CD44-overexpressing 
tumour cells and improved cytotoxicity [141]. Another 
approach to avoid irradiation with UV light of biological 
objects and induce generation of ROS is to combine TiO2 
NPs with upconverting NPs (UCNPs) such as rare earth–
based NPs [142–144]. As mentioned above, NIR light is 
able to penetrate deeper into cells and tissues and has 
minimal photodamage [145]. One of the main features of 
the UCNPs is their ability to absorb light energy in NIR 
region and convert it into UV light due to the unique 
ladder-like structure of energy levels of lanthanide ions 
[144]. Yin et al. [146] developed NaGdF4, Yb, Tm NPs as a 
core, with the TiO2 as a shell for NIR-mediated combined 
anticancer therapy. The chemotherapy was achieved by 
loading of the developed carriers with DOX, and PDT was 
provided by TiO2 shell, which expressed ROS under irra-
diation of whole system with NIR light, which was subse-
quently converted into UV light. As a result, the developed 
systems demonstrated an increased cancer cell (MDA-MB-
231) death [146]. To shift the activation of TiO2 NPs into the 
visible light spectrum, TiO2 NPs can be grafted with some 
transition metal oxides such as iron oxide NPs (IONPs). 
Therefore, the nanocomposites (TiO2–IONPs) can be 
applied as visible light–sensitive PSs for PDT. Zhang et al. 
[147] developed TiO2–Fe3O4 complexes, which generated 
ROS under visible light. Additionally, these complexes 
were loaded with Fe2+-dependent drug artemisinin, and 
the surface was modified with HA to induce HA-mediated 
endocytosis. According to the obtained results, the devel-
oped systems induced an improved tumour inhibition 
in vitro and in vivo (Figure 9B) [147].
3.2.3   Iron oxide NPs
Magnetic IONPs are widely used particles (some of them 
are already clinically approved) in biology and medicine 
as MRI contrast agents, in magnetic hyperthermia appli-
cations, and others [149–151]. Despite the magnetic prop-
erties of IONCs, recent studies demonstrated that highly 
crystalline IONPs possess also thermal response on NIR 
light [152], which can be effectively used in PTT. The mech-
anism of photothermal energy conversion has not been 
fully understood. This phenomenon can be explained 
by high density of defects in the electronic structure of 
Fe3O4 NPs. These defects can be attributed to the mixed 
valences of neighbouring cation ions (Fe2+ and Fe3+) of 
the inverse spinel-structured Fe3O4 NPs [153]. Therefore, 
the narrowing of the band gap takes place with the con-
sequence formation of oxygen vacancies. The heating 
then subsequently occurs under NIR light, when optically 
excited electrons exchange transitions from the different 
defects, which is related to the different band gap ener-
gies [154]. The highly crystalline IONPs are usually syn-
thesised by thermal decomposition method with further 
coating of NPs with polymers to make them water-solu-
ble, which is essential for biomedical applications. Chen 
et  al. [152] reported on the concentration-dependent 
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temperature increase up to 56°C [0.5  mg(Fe)/ml] when 
Fe3O4 NPs were irradiated with light. After intravenous 
administration into SUM-159 tumour-bearing mice, 
IONPs could effectively accumulate within the tumour 
(5.3% of injection dose) due to enhanced permeability 
and retention effect. After NIR irradiation of the tumour 
zone, complete tumour regression was observed [152]. In 
another study, Oh et al. [155] showed combined PTT and 
chemotherapy after administration of highly crystalline 
Fe3O4 NPs loaded with DOX. The enhanced cytotoxicity 
of human breast cancer cells (MDA-MB-231) was induced 
by synergetic effect from heat under NIR-laser irradia-
tion and released DOX [155]. Shen et  al. [156] developed 
temperature-responsive drug carriers based on IONPs. In 
this work, Fe3O4 NPs were coated with temperature-sen-
sitive polymer, which was postloaded with DOX. The NIR 
irradiation of Fe3O4 induced increase in the temperature, 
which resulted in the polymer shrink with the subsequent 
release of DOX. These NIR-light–responsive drug delivery 
systems were tested in vitro and in vivo. The revealed data 
Figure 9: Example of light-treatment with inorganic NPs.
(A) Schematic diagram of employment of silica NPs as light-sensitive drug carriers. (B) In vivo NIR imaging of tumour-bearing mice 
intravenous injected with free NIR-dye (IR783) solution (upper row) and IR783-loaded HA–TiO2–IONPs (lower row) at different times after 
injection. (C) Thermal images obtained with the IR camera in mouse, after intratumoural injection IONPs, in the left-hand tumour, and after 
10-min application of AMF, NIR-laser irradiation, or DUAL (both effects). Reprinted with permission from [125, 147, 148]. Copyright 2015 John 
Wiley and Sons; Copyright 2017 Impact Journals; Copyright 2016 American Chemical Society.
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demonstrated tumour inhibition rate of up to 91.5% [156]. 
Apart from MRI, the additional functionalisation of IONPs 
with carbon can provide fluorescence properties enabling 
dual-modal imaging. Wang et  al. [157] developed multi-
functional carriers that comprised Fe3O4 as a core material 
and carbon as a shell material. These carriers exhibited 
NIR, upconverted, and wavelength-tunable fluorescence 
properties. The multimodal imaging and PTT were probed 
on mice bearing C6 glioblastoma and resulted in improved 
tumour therapy [157]. In another study, Wang et al. [158] 
combined magnetic and upconversion properties in one 
particulate system for PDT. Optically and magnetically 
responsive liquid marbles based on NaYF4 nanocrystals 
and doped with Yb3+/Er3+/Gd3+ were loaded with proto-
porphyrin IX to produce ROS. In the developed system, 
UCNP outer layer acted as a light transducer to introduce 
photons with higher energy that are necessary to activate 
PSs [158]. As mentioned above, highly crystalline IONPs 
are capable of being heated under alternating magnetic 
field and NIR irradiation. This feature of IONPs was exam-
ined by Espinosa et al. [148], where iron oxide nanocubes 
were injected into the tumour of 8-week-old female immu-
nodeficient athymic nude NMRI mice. Laboratory animals 
were treated simultaneously with alternating magnetic 
field and NIR-laser irradiation. The revealed data showed 
the twofold to fivefold amplification of heat in the tumour 
area compared with magnetic stimulation alone. These 
dual-mode treatment resulted in complete tumour regres-
sion (Figure 9C) [148].
3.2.4   Lanthanide-doped UCNPs
Recently, UCNPs doped with lanthanide ions have 
emerged a great potential as drug delivery carriers due to 
possibility to control carrier fate inside cells and labora-
tory animals with optical microscopy (deep optical bioim-
aging). Indeed, UCNPs are able to absorb light with lower 
energies (NIR) and convert in high-energy radiation (UV/
visible). Detailed explanation of this phenomenon can be 
found in the studies of Escudero et al. [144] and Bagheri 
et al. [159]. Therefore, remarkable advantages that include 
enhanced biological tissue penetration depths, less 
photodamage, and good biocompatibility make UCNPs 
preferable as light-responsive delivery carriers. Lantha-
nide-doped UCNPs of different sizes and shapes can be 
synthesised with wet chemical methods. These methods 
are generally based on precipitation reactions. In order to 
obtain monodisperse uniform NPs, the controlled release 
of cations and/or anions, as well as appropriate reaction 
kinetics, is required [142, 143].
Apart from bioimaging, UCNPs can be used as a source 
to induce drug release through photodegradation of PSs 
that should be incorporated into drug carrier. Indeed, Yao 
et al. [160] demonstrated light-induced release of antican-
cer drug from carriers based on UCNPs incorporated into 
AZO amphiphilic molecules, which are sensitive to NIR 
to UV/vis upconversion luminescence. They can trans-
form the trans-isomer into the cis-isomer under UV light 
and conversely the cis-isomer into the trans-isomer under 
visible light. Authors probed release of DOX using NIR 
light (980 nm) on the model of MCF-7/ADR tumour borne 
by nude mice [160]. In another study, photocleavable moi-
eties were conjugated to the surface of UCNPs to release 
chemotherapeutic upon light irradiation. For this, UCNPs 
were coated with o-phosphorylethanolamine ligands and 
coupled to an NB derivative of 5-fluorouracil. Upconverting 
NPs absorbed NIR light and emitted blue photolumines-
cence that was in resonance with the absorption band of 
NB derivative of 5-fluorouracil. This resulted in photocleav-
age with subsequent release of drug [161]. Another photo-
cleavable delivery system was developed by Xing et  al. 
[162]. Photoresponsive copolymer modified with folic acid 
was conjugated with UCNPs (NaYF4,Yb3+,Tm3+). The devel-
oped carriers were then exposed to NIR light with subse-
quent release of DOX in a sustained manner [162]. Jalani 
et al. [163] developed NIR-sensitive delivery systems based 
on UCNPs (LiYF4,Yb3+,Tm3+) coated with chitosan hydro-
gel cross-linked with a photocleavable cross-linker. Under 
980 nm excitation, UV emission cleaved cross-linked and 
released loaded fluorescent BSA. The efficiency of the 
remote drug release was tested in vitro [163]. Upconvert-
ing NPs can be also used for multiple-drug loading. In the 
recent study, NaYbF4,Er UCNPs were used as core element 
for loading of several compounds: (i) antitumour drug DOX 
and (ii) tocopheryl polyethyleneglycol 1000  succinate to 
overcome multidrug resistance. Both compounds were lib-
erated from the developed carriers in a prolonged manner 
in physiological conditions. Moreover, upconversion abili-
ties of carriers and strong X-ray attenuation enabled dual-
imaging modalities (luminescence and X-ray computed 
tomography), which made the developed carriers good 
candidates for imaging-guided cancer agents [164].
4   Light-responsive composite 
delivery systems: recent 
applications in nanomedicine
Recent developments in material science enable fabrica-
tion of light-sensitive drug delivery systems with complex 
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architecture taking advantages from individual delivery 
system. The main goal of composite systems is to design 
materials that possess novel functional properties such 
as enhanced drug loading, prolonged circulation times 
in vivo, multimodal imaging, and others [22, 165]. In this 
section, we discuss the recent advances in the develop-
ment and application of light-sensitive drug delivery 
systems based on polymers and on biological systems.
4.1   Composite delivery platforms based on 
organic NPs
Organic-based NPs are one of most attractive delivery 
systems, which can be easily modified with light-sensitive 
moieties. Light sensitivity of organic NP-based delivery 
systems is usually achieved through incorporation of 
specific chemical moieties or nanostructured materials 
into the polymer structure. There are several organic-
based materials, including lipids and polymers, which are 
usually used for NP fabrication [166]. The advantages of 
these materials are determined by their reduced toxicity, 
easy synthesis, and suitability for the drug encapsulation 
[167]. In this part, we review the most extensively used 
light-sensitive composite carriers based on (4.1.1) amphi-
philic macromolecules, (4.1.2) liposomes, and (4.1.3) poly-
meric particles.
4.1.1   Amphiphilic macromolecules (micelles)
Hydrophobic bioactive compounds can be encapsulated 
into the cavity of amphiphilic macromolecules, so-called 
micelles, due to the hydrophilic heads and hydrophobic 
tails. This leads to the formation of vesicle-like structure 
with hydrophobic cores [168], and on-demand delivery of 
Figure 10: Schematic illustration of different release mechanisms of photo-responsive micelles.
Reprinted with permission from [168]. Copyright 2014 Royal Society of Chemistry.
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drugs occurs by disrupting the hydrophilic–hydrophobic 
balance of the carriers. Micelles are usually synthesised 
out of biocompatible materials [169] with the incorporated 
PSs in its structure, which convert photoirradiation into a 
chemical signal. This conversion occurs through the dif-
ferent types of photoreactions such as isomerisation, rear-
rangement, cleavage, dimerisation, and heating, which 
are comprehensively described by Huang et  al. [168] 
(Figure 10).
4.1.1.1   Isomerisation
This process is accomplished by the structural changes in 
the micellar structure upon light irradiation. The typical 
photoisomerisation molecules, which are used to design 
polymeric micelles, include AZO, SP, and dithienylethene 
[157]. Molla et al. [170] fabricated AZO-containing photoi-
somerisation micelles using b-PEG-azoB-PLA. The devel-
oped systems allowed encapsulation of hydrophobic and 
hydrophilic molecules and their further release upon UV 
light [170]. Yuan et al. [171] also designed novel amphiphi-
lic AZO-containing micelles for an effective light-induced 
destruction of micelles upon UV light (360 nm).
4.1.1.2   Rearrangement
Upon light irradiation, the hydrophobic part of amphi-
philic polymers converts into hydrophilic ones, which 
results in disassembly of polymeric micelles. An example 
of such molecule involved in this process is hydropho-
bic DNQ molecule, which can be changed into a hydro-
philic 3-indenecarboxylic acid upon UV-light irradiation 
(Figure 10) [168]. Li et al. [172] developed novel DNQ-con-
taining multifunctional light-responsive micelles, where 
DNQ groups can undergo Wolff rearrangement under UV/
NIR light irradiation.
4.1.1.3   Cleavage
This mechanism is based on the break of photocleavage 
groups located in the side chain of the micelles. Photocleav-
age reaction usually occurs using photochromic NB and 
coumarin-incorporated copolymers, which are employed 
in fabrication of light-responsive micelles. As an example, 
Ji et  al. [173] showed photoresponsive poly(ethylene 
 glycol)-block-poly(o-nitrobenzyl-l-glutamate) diblock 
copolymers. These copolymers can self-assemble into spher-
ical micelles in aqueous solution. The obtained micelles 
demonstrated photoinduced transition of their morphology 
from spheres to cylinders under UV light. This phenomenon 
arises from the disruption of amphiphilicity induced by the 
cleavage of NB groups on the side chains [173].
4.1.1.4   Dimerisation
This mechanism of conformational changes in micellar 
structure is based on temperature-dependent photoin-
duced chemical bonds, which turn into the swollen state 
above the lower critical solution temperature (LCST). This 
results in the release of the pre-encapsulated drug. In the 
recent study, dual-responsive polymeric micelles were 
designed using photodimerisation process, which were 
capable of tuning the LCST of the polymer by attaching 
photosensitive moieties [174].
4.1.1.5   Heating
The heating process is associated with the conversion of 
light energy into heat. For this, the polymeric micelles 
are usually modified with inorganic particles (Au, Ag, 
and other), which possess NIR absorption. Ma et al. [175] 
reported on Au nanoshell nanomicelles with light-trig-
gered release mechanism for PTT. Authors demonstrated 
an efficient NIR-induced stepwise release behaviour of 
DOX in vitro.
Therefore, by the application of each previously men-
tioned mechanism, one can control the stabilisation of 
the micellar structure, formation/disruption of micelles, 
or cross-linking.
4.1.2   Liposomes
The great step forward in preclinical and clinical studies 
was made in employment of liposomes as drug delivery 
carriers. The synthesis of liposomes is rather straightfor-
ward and can be achieved in size-controlled manner [176]. 
Liposomes usually comprised of naturally derived phos-
pholipids, which can mimic the biological membranes 
[172]. Unlike micelles, hydrophilic and hydrophobic mole-
cules can be loaded into the structure of liposomes because 
of its lipid bilayer structure. Regarding the synthesis and 
loading of liposomes with bioactive compounds, we refer 
to the following review articles [176–178].
Liposomes can be further engineered with functional 
moieties to be light-sensitive. The most common way to 
do this is to include PSs that transfer the light energy to 
molecular oxygen with further formation of ROS. Gener-
ally, PSs are hydrophobic; therefore, encapsulation of 
these compounds in the liposomes increases their solubil-
ity, as well as delivery to the targets [179]. The mechanisms 
of the light-triggered release of cargo from the liposomes 
can be different and are similar to the micelles. They 
mostly include photoisomerisation, photocleavage of 
lipids upon exposure to light-mediated formation of ROS, 
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and photopolymerisation of lipids containing double or 
triple bonds. Another way to stimulate release of bioactive 
compounds from liposomes under light is incorporation 
of plasmonic nanostructures. Au NPs can be embedded 
into the liposomal structure either via thiol bonding or via 
electrostatic interactions, when mixing formed liposomes 
with Au NPs [180]. Under laser irradiation, because of the 
large temperature gradients, the surrounding medium 
produces bubbles, which induce rupture of liposomal 
structure with the consequent release of cargo into the 
surroundings [181]. However, Palankar et al. [182] demon-
strated that apart from rupture transient pores in liposo-
mal membrane can occur upon localised laser irradiation 
of Au NPs embedded into the structure of liposomes. This 
transient opening of liposomal membrane was monitored 
by ion current. Another mechanism of cargo release from 
liposomes modified with Au NPs is the thermic effects, 
which lead to the disintegration or melting of liposomal 
structure. For instance, Luo et al. [183] showed controlled 
release upon NIR irradiation from chitosan-coated oleic 
acid liposomes with outer layer of Au NPs. The mecha-
nism of the release in this case was activation of the gel to 
liquid crystalline phase transition of the liposomes [183]. 
In another study, Lajunen et al. [184] demonstrated light-
triggered release of fluorescence probes from liposomes 
that contained DPPC (1,2-dipalmitoyl-sn-glycero-3-phos-
phocholine) and DSPC (1,2-distearoyl-sn-glycero-3-phos-
phocholine) and modified either with Au nanorods or Au 
nanostars. The release of cargo was temperature depend-
ent, proving that with the increase in temperature disin-
tegration/melting rate of liposomes also increases [184]. 
Light-responsive liposomes can be additionally designed 
for addressable delivery of bioactive compounds. For this, 
apart from functionalisation with Au NPs (for light sen-
sitivity), surface of liposomes can be modified with tar-
geting molecules (antibodies, peptides). Indeed, Li et al. 
[185] conjugated human epidermal growth factor receptor 
2 antibody to the surface of liposomes. As a result, authors 
observed approximately twofold increase in accumulation 
of carriers in vivo near the tumour region. The targeted 
delivery did not cause systemic toxicity after injection 
[185]. In another study, peptides were applied to improve 
cellular uptake of light-sensitive liposomes. For this, 
SPACE (skin-penetrating-and-cell-entering) peptides were 
conjugated onto the surface of liposomes, which were in 
turn modified with Au NPs. Fluorescence molecules and 
nucleic acids were delivered with the developed carrier 
systems, and the release was triggered upon NIR irradia-
tion. The authors claimed the mechanism that induced 
the intracellular release was the vapour bubble formation, 
which led to the mechanical disruption of liposomes [186]. 
In the recent in vivo study, Li et al. [187] combined PDT and 
chemotherapy in one light-responsive liposomal carrier. 
For this, PSs (ICG-ODA) as well as DOX were incorporated 
into the structure of liposomes. The combined therapy led 
to the significant inhibition of tumour growth compared 
to the PDT or chemotherapy alone [187].
4.1.3   Polymers
Light-responsive polymeric delivery systems are under 
extensive investigation in the past decade. The basic prin-
ciple of polymer carriers’ synthesis is comprehensively 
described in the recent review article [22] and based on 
so-called layer-by-layer technique, which consists of dep-
osition of oppositely charged polymers onto the sacrificial 
template [188]. After the dissolution of template, hollow 
polymer capsules can be produced, which in turn can be 
loaded with various bioactive compounds, such as drugs 
[189], nucleic acids [190], macromolecules [9], fluorescent 
moieties [191], and other. Generally, to impart polymer cap-
sules properties of light sensitivity, their shell should be 
modified with plasmonic/dielectric NPs. These NPs can be 
simply attached onto the polymeric shell via electrostatic 
interactions. The main mechanism of intracellular cargo 
release from the polymer capsules upon laser irradiation is 
the temperature increase, which leads to the change of the 
permeability of the polymer shell and thus the triggered 
release of cargo [9, 192, 193]. The detailed description of 
thermodynamics and temperature rise inside polymer 
capsules modified with plasmonic NPs is provided in the 
recent works [194, 195]. In the pioneer works, aggregated 
Au NPs were employed as heat agents embedded into the 
polymeric shell [196]. Indeed, Skirtach et al. [197] used Au 
and Au sulphide NPs for modification of polymer capsule 
wall. Activation of capsules was achieved using NIR-laser 
irradiation (830  nm) with the subsequence release of 
loaded fluorescent dye inside cancer cells [197]. Initial size 
of Au NPs was 15 nm in diameter, which has the maximum 
of plasmon band at approximately 520 nm. However, the 
aggregation of 15 nm NPs results in red shift and broaden-
ing of plasmon band of Au NPs [198], which is more suf-
ficient for NIR-light irradiation. In this study, fluorescence 
molecules were delivered into cytosol of individual A549 
cell upon laser irradiation. The similar Au NP aggregates, 
embedded into the polymeric shell of capsules, were used 
for the in vivo release of adenosine triphosphate in order 
to activate Wnt signalling pathway in the small freshwater 
polyp Hydra vulgaris (Figure 11A) [199]. In another study, 
polymer capsules with outer silica layer were also modi-
fied with Au NP aggregates in order to deliver pH-sensitive 
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fluorescent molecules upon laser irradiation. Additional 
layer was introduced to encapsulate low-molecular-weight 
cargo, which was not able to diffuse through the dense Si 
layer [200]. The synthesis procedure of polymer capsules 
with embedded Au aggregates cannot be fully controlled, 
as the induction of NP aggregates is a statistical process. 
Therefore, in this case, it is not always possible to achieve 
a good match of applied wavelength of laser irradiation 
with the maximum peak of the plasmon band. For this 
reason, other types of heating agents were applied to 
achieve more efficient NP heating at the same laser power 
density. In the recent study, Au nanostars with the narrow 
size distribution and the absorption maximum at approxi-
mately 800 nm were employed to functionalise polymeric 
Figure 11: Light-induced release of bioactive compounds from composite polymer carriers.
(A) NIR-triggered activation of Wnt signalling pathway, (top) schematic diagram of experimental procedure, (left bottom) untreated animal, 
irradiated, (right bottom) animal treated with light-sensitive capsules and irradiated. Scale bars correspond to 500 μm. (B) Fluorescence and 
overlay (fluorescence + bright field channel) images of cells incubated with light-sensitive capsules. In (2–4), images are shown after three 
illumination steps. The scale bar corresponds to 20 μm. Reprinted from [9, 199]. Copyright 2016 American Chemical Society; Copyright 2018 
by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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capsules. Kantner et al. [9] demonstrated successful cell-
by-cell laser-induced staining, which were realised with 
polymer capsules modified with Au nanostars. As fluo-
rescence markers, DAPI (4′,6-diamidino-2-phenylindole), 
propidium iodide, phalloidin conjugated with dye, and 
wheat germ agglutinin conjugated with dye were used. 
Authors additionally performed intracellular staining of 
cells with polymer capsules loaded with different cargoes 
upon laser irradiation (Figure 11B) [9]. As an alternative to 
Au nanostars, Au nanorods can be used as heating agents 
in the polymer capsules wall, as Au nanorods possess two 
plasmon peaks (transversal and longitudinal) [201]. One of 
these peaks is situated in the NIR region, which is suitable 
for biomedical applications. In the recent work, polymer 
capsules modified with Au nanorods were employed to 
functionalise surface of scaffolds, which can be used as a 
frame for the new tissue formation. Capsules were loaded 
with hormone (dexamethasone), which in combination 
with β-glycerophosphate stimulates differentiation of 
mesenchymal stem cells (MSCs) in osteogenic direction in 
vitro. Burst-like release of bioactive compounds onto the 
scaffolds surface was probed using NIR-laser irradiation 
[202]. In recent studies, Au nanorods were also employed 
to induce noninvasive release of drugs from polymer cap-
sules in vivo. Upon NIR irradiation at used laser power 
density 0.54 J cm−1 DOX was released inside bearing nude 
mice [203, 204]. Unusual shape of light-sensitive drug 
carriers was reported by Wu et  al. [205], where polymer 
tubes were functionalised with Au NPs. Theoretical and 
experimental study demonstrated the explosion of devel-
oped systems upon laser irradiation. Authors claimed that 
mechanism of tube explosion is based on rapid evapora-
tion of water inside tubes caused by photothermal effects 
[205]. Not only plasmonic NPs can be employed as nano-
heaters into the capsules wall. Kurapati and Raichur 
[206] embedded GO into polymer capsules, which pos-
sesses superior optical absorption and photothermal 
conversion. Thus, GO-modified polymer capsules were 
also developed to be NIR light–sensitive [206]. Diversity 
of polymer capsules enables encapsulation of different 
nanostructures at the same time. For instance, Yashche-
nok et  al. [207] incorporated Au NPs and single-walled 
carbon nanotubes (SWCNs) into the polymer capsule wall 
in order to perform thermometry at the nanoscale. Au NPs 
were employed as nanoheaters, and SWCNs as Raman 
nanothermometers. The obtained results demonstrated 
that upon NIR light irradiation the temperature of com-
posite polymer capsule destruction was 348 K for a power 
density of 31.8 × 104  W · cm−2 [207]. It is worth mention-
ing that incorporation of nanostructured materials (e.g. 
plasmonic NPs) into the polymer capsule shell enables 
not only noninvasive light-induced drug delivery but 
also imaging of intracellular environment with e.g. pho-
toacoustic imaging technique. This results in theranostic 
platform for an effective therapy and diagnosis [208, 209].
4.2   Composite light-sensitive bioinspired 
delivery platforms
Most of organic and inorganic drug carriers, which are 
responsive to light, do not reach clinical trials. Only some of 
them are officially approved by the Food and Drug Admin-
istration [24]. The main barrier between the development 
of the light-sensitive drug carriers and their translation 
into clinics is attributed to the ability of the organism to 
recognise and remove foreign biomaterial. Therefore, the 
novel design of the drug delivery platforms is required to 
protect the carriers from the cell immune system [24, 210]. 
Therefore, biomimetic-based approaches that attempt to 
imitate the real biological situation in cells and tissues are 
of great interest. Such delivery systems transfer specific 
biological functionalities to synthetic drug carriers [24, 
211]. Light-responsive biological (bioinspired) drug carri-
ers can be considered as one of the most attractive delivery 
systems, replicating features that are similar to the biologi-
cal objects [212]. The main advantages of bioinspired car-
riers are their ability to interact with specific sites of the 
body, their cell/tissue entering mechanisms, capability to 
avoid the immune responses, and prolonged circulation 
times in biological fluids [212, 213]. Light-responsive bioin-
spired carriers include the use of (4.2.1) mammalian cells, 
(4.2.2) bacteria, and (4.2.3) viruses (Figure 12).
4.2.1   Cell-based drug carriers
Cell-based delivery systems attract tremendous atten-
tion because of the treatment ability of various diseases 
including oncology, diabetes, hemophilia, and cardio-
myopathy. At the same time, cell engineering in combina-
tion with the designed nanoparticles and microparticles 
enables fabrication of biomimetic light-responsive plat-
forms for the delivery of different bioactive compounds. 
Among different therapeutically relevant cells, RBCs, 
immune cells, SCs are widely employed as bioinspired 
drug delivery platforms and will be further discussed in 
details [214, 215].
4.2.1.1   Red blood cells
After in vivo administration, therapeutic formulations rely 
predominantly on the vascular system for the effective 
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biodistribution and accumulation at the target site. RBCs 
or erythrocytes are the most abundant cells in the human 
blood system (approximately 99% of the total amount of 
blood cells). RBCs have an average lifespan of 120  days 
without being cleared by macrophages. In comparison, the 
lifespan of the PEGylated drug carriers, which is known to 
have prolonged circulation times, is approximately 10  h 
[216, 217]. RBCs have a diameter of 7–8 μm and an average 
volume of 90 fl oz; they lack a nucleus and can change 
their shape to fit through the blood vessels. Erythrocytes 
confine the unintended extravasation and extend the cir-
culation time in the body, which in combination with high 
cargo loading capacity, excellent biocompatibility, and low 
immunogenicity makes them as excellent drug delivery 
systems [216, 218]. RBCs can be reversibly opened under 
hypotonic conditions to inject exogenous compounds upon 
resealing of membrane pores. Another method of RBC drug 
loading involves the attachment of drug molecules to the 
cell surface through biotin, affinity ligands, or nonspe-
cific interactions such as van der Waals forces, hydrogen 
bonding, or electrostatic or hydrophobic forces [215, 216].
For the controlled therapy, the RBC membranes can be 
modified with light-responsible agents. Delcea et al. [219] 
reported on RBCs modified with aggregates of Au NPs with 
high NIR absorbance. The attachment of Au NPs to RBCs 
was verified with Raman spectroscopy. The mechanism 
of the drug release was the heating of the lipid bilayer 
and/or transmembrane proteins. The developed system 
demonstrated improved drug release from the RBC biocar-
riers upon NIR-laser irradiation. Gao et al. [220] developed 
a cell-based delivery system composed of RBCs modified 
with the PS chlorin e6, which was incorporated into the 
membrane of erythrocytes upon mixing without disturb-
ing the membrane structure. To achieve chemotherapeu-
tic effect, DOX was introduced into the inner aqueous 
cavities of RBCs. The mechanism of photoinduced release 
of the drug was the break of cells’ membrane upon laser 
irradiation. The resulted drug delivery platform possessed 
synergetic therapeutic effect from generation of ROS 
(PDT) and chemotherapy upon exposure to the 660-nm 
light [220]. However, the RBC-based delivery systems 
have some limitations. The main disadvantage of the RBC 
implementation as drug carriers is their ex vivo modifica-
tions including hemotransfusion (transferring of blood 
or blood products intravenously), which limit their wide 
application. Another challenge of the RBC employment 
as delivery carriers is their loading with drugs, which can 
sometimes lead to the change of their structural and func-
tional properties [216, 221].
4.2.1.2   Immune cells
Another promising type of cell-based drug delivery plat-
form is immune cells or white blood cells (WBCs). The 
Figure 12: Schematic illustration of implementation of bioinspired light-sensitive carriers.
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main feature of immune cells is the response to inju-
ries. Damage tissues produce signalling molecules such 
as chemokines and cytokines, which attract immune 
cells that infiltrate into the damage sites, e.g. infection, 
inflammation, tissue injury, and cancer. Immune cells 
are capable of deep penetration into tissues compared to 
the conventional drugs [222, 223]. The size of WBCs varies 
from 7 μm (small lymphocytes) to 20 μm (monocyte) [224]. 
The WBCs derived from the body can be loaded in vitro 
with drugs without any apparent toxic effects and rein-
jected into the blood. Immune cells can be also modified 
with light-responsive agents for the noninvasive therapy 
of cancer [225, 226].
There are different types of WBCs (leukocytes) such 
as neutrophils, lymphocytes, and macrophages, which 
can be employed as cell-based drug delivery vehicles to 
mediate the delivery across the biological barriers. The 
modification of leukocytes with light-responsive agents 
enables the release the drugs to targeted sites upon laser 
irradiation. The key feature of leukocytes is their migra-
tion abilities towards inflammatory area and adhesion to 
endothelial wall tissues with tumour cells [212, 223, 227].
Neutrophils present the most abundant leukocyte 
in the human organism. They are the first cell type that 
appears at the damage sites and secrete cytokines to 
recruit other cells. Neutrophils have a short lifespan 
(approximately 5 days) in blood circulation and only a few 
hours after isolation from the body. On the one hand, their 
shorter lifespan limits neutrophil applications in drug 
delivery. However, their ability to be instantly recruited 
makes these cells attractive as drug vehicles [228]. Chu 
et al. [229] showed a drug delivery system based on fluo-
rescent polystyrene NPs coated with anti-CD11b antibod-
ies via biotin–neutravidin binding that target activated 
neutrophils. The migration of the developed platforms 
was induced by neutrophils with the following infiltration 
into tumour. To achieve PTT, neutrophils were decorated 
with Au NPs. The neutrophil uptake of NPs did not alter 
neutrophil activation and transmigration. The developed 
cell-based delivery system possessed features of com-
bined PTT and PDT under 660 nm light [229].
Lymphocytes are primarily presented in the blood 
circulation and lymphoid organs (spleen, tonsils, lymph 
nodes). T and B cells are the main types of lymphocytes 
that are responsible for the adaptive immune system. 
T cells play a key role in cell-mediated immunity, whereas 
B cells are involved in humoural immunity. Both T and 
B cells present multiple functions in the organism and 
are involved in numerous processes such as detect-
ing antigens, infiltrating damage tissues, and attacking 
abnormal cells [228]. The advantages of drug delivery 
by lymphocytes are their migration and accumulation 
inside the tumour areas. Moreover, such delivery system 
can detect and attack metastases that are hard to be 
diagnosed [215, 230]. Another type of lymphocytes, so-
called NK cells, can more effectively attack infections 
and tumours [231]. They constitute approximately 10% of 
circulating lymphocytes and, unlike T lymphocytes, can 
eliminate target cells spontaneously without antigen-
specific stimulation. Deng et  al. [232] designed NK cell 
membranes decorated with NPs loaded with PSs. Photo-
sensitizers [4,4′,4″,4‴-(porphine-5,10,15,20-tetrayl) tetra-
kis (benzoic acid)] loaded into NK carriers enhanced NK 
cell immunotherapy and eradicated primary tumour cells 
through PDT [232].
Macrophages are mononuclear phagocytes that play a 
crucial role in eliminating pathogens and cellular debris. 
They can act as antigen-presenting cells and secrete 
various types of bioactive compounds to communicate 
with other immune cells [233]. Macrophages can engulf 
different molecules based on specific receptor interactions 
and their phagocytic capabilities [216]. Choi et  al. [234] 
used macrophages to deliver Au nanoshells to the tumour 
hypoxic regions. After application of NIR light, cancer 
cells were destroyed within these tumour areas [234]. 
Other works demonstrated the migratory potential of drug-
loaded macrophages in glioma both in vitro (tumour sphe-
roids) and in vivo (mice models) [225, 235]. In the first work, 
Au nanoshells were used to modify macrophages and to 
suppress tumour spheroid growth upon NIR-laser irradia-
tion. As the NPs are not able to cross the patent blood-brain 
barrier, macrophages can overcome this limitation. In the 
second work, authors demonstrated that macrophages 
readily traverse the blood-brain barrier, where residual 
glioma cells were found after surgery. Macrophages have 
the potential to increase NP delivery to different types of 
tumours including glioblastoma multiforme [225].
Overall, immune cells have a quick response and 
intrinsic homing properties with respect to damaged 
tissues and tumours. The sensitive detection of target sites 
and abilities to overcome biological barriers can facili-
tate drug delivery. However, among the available immune 
cells, leukocytes are difficult to cultivate and handle. They 
have relatively short lifespans, which hinder the manipu-
lation processes for the drug loading [215].
4.2.1.3   Stem cells
Stem cells, in particular, MSCs, have attracted great inter-
est because of their properties of intrinsic inflammation 
and tumour tropism. Because of the property of active 
migration towards tumours and penetration tumours, SCs 
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are applied as bioinspired carriers with wide possibilities 
of drug loading such as apoptosis-inducing and antiangio-
genic factors, cytotoxic chemotherapy, immunomodula-
tory agents, oncolytic viruses, drug-loaded microparticles 
and NPs, and tissue- or tumour-specific prodrugs [236, 
237]. The cytokine release in the tumour stroma and the 
interaction of MSCs with cytokine and chemokine recep-
tors present on the cell surfaces are mainly responsible for 
their migration towards tumours [238, 239]. Xu et al. [240] 
developed a synergistic treatment platform based on MSCs 
loaded with light-responsive plasmonic–magnetic hybrid 
NPs containing lipids, DOX, Au nanorods, and Fe3O4 nano-
cluster (MSCs–LDGI) for photoacoustic imaging, targeted 
PTT, and chemotherapy against triple-negative breast 
cancer. Mesenchymal stem cells–LDGI maintained good 
bioactivity to migrate towards cancer cells both in vitro and 
in vivo. The disassembly of the developed nanostructures 
with the subsequence drug release was probed upon light 
irradiation. In vitro and in vivo experiments showed that 
the MSCs–LDGI efficiently inhibited cancer cell growth 
and implemented good therapeutic effects via both local 
and intravenous injection routes [240]. In recent work, 
Muslimov et  al. [241] developed the light-sensitive MSCs-
based delivery system. Antitumour drug was encapsulated 
into composite capsules functionalised with Au nanorods. 
In turn, capsules were used to modify MSCs. Upon NIR-
laser irradiation, composite capsules were disintegrated 
because of the thermal effects. The efficiency of the devel-
oped MSC-based delivery system was probed on model 
of melanoma spheroids. NIR–triggered drug release indi-
cated the higher antitumour efficiency of bioinspired plat-
form compared to the free drug (Figure 13) [241].
4.2.2   Bacteria-based drug carriers
Pathogens such as bacteria have developed unique strat-
egies to avoid the immune response and induce favour-
able interactions with host target cells [71]. Bacteria can 
penetrate even nonphagocytic mammalian cells by spe-
cific surface molecules. Bacteria can successfully grow 
in tumour sites because of the impaired blood circulation 
and large necrosis area of solid tumours [242]. Bacteria 
have the full complement of ribonucleic acid (RNA) poly-
merases, and they are able to deliver or produce these pro-
teins at the target site [243]. Bacteria-based engineering 
strategies for drug delivery include recombinant bacteria, 
microbots, and bacterial ghosts.
Figure 13: Addressable drug delivery using light-sensitive MSCs-based delivery platform. 
(A) Schematic diagram of the experimental procedure. (B) Confocal microscopy images of tumour spheroids with and without NIR-laser 
irradiation incubated with (left) free antitumour drug, (middle) polymer light-sensitive particles loaded with antitumour drug, (right) MSC-
modified polymer light-sensitive particles loaded with antitumour drug. Living cells were stained with calcein AM (green); nuclei of dead 
cells were stained with propidium iodide (red). Scale bars correspond to 100 μm. Reprinted with permission from [241]. Copyright 2019 
Royal Society of Chemistry.
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Recombinant bacteria are carriers that are genetically 
modified by the expression systems encoding proteins 
and antigens [71]. Hosseinidoust et al. [243] developed an 
optogenetic and light-sensitive delivery system based on 
recombinant bacteria using an engineered bacterial light-
oxygen-voltage protein that bonded DNA when illumi-
nated with blue light. The system showed a high dynamic 
range of protein expression, rapid activation, and deac-
tivation kinetics in vitro. The recombinant bacteria were 
employed to activate transcription in different eukaryotic 
systems (mammalian cell lines and zebrafish embryos) 
upon stimulation with blue light [243–245].
Microbots are bacteria that transfer drug agents 
attached onto their surface. Microbots do not require 
genetic modifications for the drug delivery. This approach 
employs the invasive properties of bacteria that are able 
to migrate into the tumours, which cannot be reached 
by conventional chemotherapy. The genetically unmodi-
fied bacteria can be conjugated with the NPs via biotin–
streptavidin interactions or different chemical-labile 
linkers [246] (Figure 14A). Luo et al. [248] reported on the 
bacteria-mediated targeting hypoxia (oxygen reduced 
tumour) to offer the expandable spectra for cancer 
theranostics. The authors developed two drug delivery 
approaches including a cargo-carrying method and an 
antibody-directed method. These approaches allowed 
delivering upconversion nanorods for imaging and Au 
nanorods for PTT ablation upon NIR light excitation. The 
antibody-directed strategy demonstrated more effective 
treatment giving high-level bioimaging, longer retention 
period, and effective therapy of tumours [248].
Bacterial ghosts are empty cell envelopes of Gram-neg-
ative bacteria. In bacterial ghosts, plasma components with 
all genetic material are removed. They can be produced by 
controlled expression of the cloned lysis gene E from bacte-
riophage species, generating a lysis tunnel structure within 
the envelope of the living bacteria [249]. Bacterial ghosts 
keep cellular morphology similar to native bacteria, where 
the entire surface structures including adhesins, membrane 
proteins, lipopolysaccharides, and the peptidoglycan layer 
are preserved [250]. Drug carriers can be also obtained 
from bacterial outer membrane vesicles [251]. Gujrati et al. 
Figure 14: Drug delivery using light-sensitive bacteria and viruses. 
(A) Schematic diagram of the bacterial microbots to load, deliver, and release active drugs for cancer therapy. (B) Cellular uptake 
mechanisms of viruses. Reprinted with permission from [246, 247]. Copyright 2018 Elsevier, Copyright 2017 Ivyspring.
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[252] developed bioengineered bacteria vesicles for both 
contrast enhancement in photoacoustic imaging and PTT. 
These bacterial vesicles demonstrated several advantages, 
as they possessed a rigid membrane with high stability and 
reduced leakage in the systemic circulation. The authors 
obtained bacteria vesicles with encapsulated melanin 
using an Escherichia coli strain. This bacterial strain was 
previously modified to be less endotoxic and to overex-
press tyrosinase, which produces melanin that is passively 
incorporated into the cytosol and membrane of vesicles. 
The obtained results indicated that upon NIR light irradia-
tion bacteria vesicles with melanin generated strong optoa-
coustic signals appropriate for bioimaging applications. 
In addition, the developed bacteria vesicles released heat 
upon NIR-laser irradiation, which resulted in photothermal 
effects both in vitro and in vivo [252].
4.2.3   Viruses-based drug carriers
Viruses are infectious microorganisms consisting of 
nucleic acids in a protein coating (capsid). Viruses 
possess several properties that can be effectively used for 
the development of bioinspired drug delivery carriers. As 
previously discussed, an ideal drug carrier should avoid 
host cell immune response, and target cells of interest 
with further release of the loaded cargo into the cyto-
plasm. These processes fully describe the early stage of 
the virus infection. Viruses naturally evolved to deliver 
genetic material into target cells. Moreover, viruses can 
evade host body protection and reach specific tissues or 
cells. Once viruses are taken up by host cells, they colo-
nise the intracellular space and release the DNA or RNA 
to replicate themselves (Figure 14B). Viruses utilise their 
protein components to overcome cellular barriers. Drug 
delivery technologies can learn a great deal from viruses 
[247].
Viral vectors were one of the first systems to deliver 
specific genes. Such vectors included inactivated adenovi-
ruses, adeno-associated viruses, retroviruses, and lentivi-
ruses. Viral vectors had to transfer only the required genes 
to the target cells. For this, they were modified to minimise 
the risk of their expansion. The process of inactivation 
involved the deletion of a part of the viral genome critical 
for the viral replication. Such vectors can infect cells but 
are not able to produce the new virions without a helper 
virus [24, 253, 254]. Viral vectors can be also modified for an 
effective PTT. Everts et al. [255] covalently bound adenovi-
ral vectors with Au NPs, so that the developed engineered 
systems successfully retargeted a tumour-associated car-
cinoembryonic antigen without losing the viral vector 
infectivity. Jung et  al. [256] explored the combination of 
oncolytic adenovirus and Au nanorod–mediated hyper-
thermia to improve antitumour effect against head and 
neck cancer. Exposure of the virus–Au nanorods system 
to light improved endocytosis of oncolytic adenovirus, 
transgene expression, and subsequent cytolysis of head 
and neck cancer cells [256]. In another study, Pandori 
et  al. developed light-responsive viruses-based delivery 
system by conjugating photocleavable moieties to viral 
components, which possessed no infectivity. The expo-
sure of the modified viruses to the UV light induced the 
modification of photocleavable moieties, which resulted 
in restoration of the virus infectivity [257].
5   Conclusion and outlook
Light-responsive nanostructured materials are success-
fully employed in the field of nanomedicine for the 
delivery of drugs. Given the nature of particles, different 
mechanisms can be employed for the release of bioac-
tive compounds. In this review article, we considered two 
major groups of light-sensitive carriers, plain and com-
posite. Each group consisted of either plasmonics and 
 dielectric NPs, or organic and bioinspired drug carriers.
5.1   Plasmonic NPs
As discussed above, plasmonic NPs (Au and Ag) and their 
combination open up a great potential for the develop-
ment of optically responsive drug delivery platforms. The 
rational design and fabrication of anisotropic Ag and 
Au NPs with different morphology (e.g. shape and size) 
provide various strategies for light-induced cancer treat-
ment. The fundamental, careful, and accurate investiga-
tions of Ag/Au NP morphology on cellular toxicity and 
behaviour are highly demanded. Also, chemical stability 
of Ag or Au NPs in biological fluids is required. The surface 
coating of Au/Ag NPs with biopolymers or proteins sig-
nificantly increases their application in medicine for drug 
delivery. At present, the main stream in application of 
plasmonic NPs as drug carriers is devoted to the develop-
ment of combinational Au- or Ag-based nanocarriers.
5.2   Dielectric NPs
Compared to plasmonic NPs, dielectric NPs are not widely 
used as drug delivery carriers. However, similar to plas-
monic NPs, Si NPs are excellent nanoheaters, and based 
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on their size and shape, they can be excited in the wide-
range spectrum [26]. This feature of Si NPs in combination 
with an effective field enhancement [123] can be success-
fully used in PTT of malignant neoplasms with simulta-
neous visualisation of NP biodistribution in  vivo with 
optical fluorescence microscopy. For this, Si NPs should 
be modified with fluorescence molecules, which requires 
additional synthetic steps. Bioimaging of TiO2 NPs is also 
not straightforward, and it requires additional surface 
modification. With the progress in material science, the 
limitations of the employment of UV light for biological 
tissues to induce generation of ROS can be overcome by 
the doping/modification of TiO2 NPs with other materials 
(rare earth, magnetic); therefore, irradiation wavelength 
can be shifted to areas with lower energies. Iron oxide NPs 
can also act as nanoheaters, which in combination with 
external alternating magnetic field (AMF) significantly 
improves PTT providing synergetic effect from magnetic 
field and light energy. Upconverting NPs are currently 
under an extensive investigation, as they are nonphoto-
toxic with wide surface functionalisation possibilities. 
However, there are some limitations that still need to be 
improved. First is the relatively low quantum yield of the 
converted light, which requires higher power excitation. 
Moreover, stability of lanthanide dopants, as well as pho-
toresponsive moieties, needs to be further investigated 
prior to in vivo applications. All discussed types of dielec-
tric NPs are promising drug delivery carriers with certain 
benefits and drawbacks; however, IONPs are closer to 
the real clinical applications, as this material is clinically 
approved, and clinical trials on humans were already con-
ducted [258, 259].
5.3   Composite delivery systems based on 
organic NPs
To combine therapeutic and diagnostic properties in one 
carrier, composite delivery systems are under intensive 
investigation. Indeed, composite organic NPs are often 
utilised to optimise delivery of bioactive compounds, to 
prolong circulation time, to enable bioimaging, and to 
provide combined therapy (e.g. chemotherapy and PDT). 
Easy modification of micelles and liposomes with light-
sensitive moieties enables controllable drug release upon 
laser irradiation. However, prior to complete implemen-
tation of micelles and liposomes in clinics, some issues 
should be addressed. First, biodegradability and bio-
compatibility of these carriers, as well as their products 
after photoreaction, should be improved. Another issue 
that needs to be solved is NIR-sensitive micelles and 
liposomes that are of urgent need. For this, multiphoton-
reaction mechanisms are required, which will result in 
a wider application of micelles and liposomes in nano-
medicine. Despite biocompatibility, easy synthesis, wide 
functionalisation possibilities, polymer capsules are also 
still not introduced into clinics because of the short circu-
lation time and large size, which are not always optimal 
for in vivo applications. Therefore, light-sensitive bioin-
spired drug delivery platforms can help to overcome the 
abovementioned limitations of composite carriers based 
on organic polymers.
5.4   Bioinspired delivery platforms
These delivery systems based on cells, bacteria, or viruses 
loaded with the pharmaceuticals (or contrast agents for 
imaging) retain their biological functions: their distribu-
tion will mimic their natural movement to the disease 
areas. However, despite all the advantages of light-respon-
sive bioinspired delivery platforms, large size of cells can 
be a significant physical barrier that prevents complete 
dispersion of these cells in small vessels of the vascular 
network. This fact limits access of exogenously introduced 
cells to many target sites, including tumour tissues [236, 
240]. Despite the advantages of discussed bacteria-based 
drug systems, there are several challenges in their devel-
opment and utilisation. First, the toxicity of bacterial drug 
carriers still remains a serious limitation. The bacteria-
induced toxicity at the therapeutic efficacy dose can cause 
a rapid bacteria clearance or autoimmune response. The 
second challenge is drug loading. Loading of agents with 
average sizes of hundreds nanometers affects the motion 
of bacteria, diffusion from blood vessels, and migration 
into tumours. The third concern is the lack of tissue dis-
tribution profile of bacterial carriers. Moreover, anaerobic 
bacteria can selectively infect and break hypoxic regions 
but leave a well-oxygenated outer rim of the tumours that 
can lead to tumour regrowth [242, 246]. The viruses-based 
delivery systems also suffer from limitations such as a 
potential immunogenicity, pathogenicity, and the broad 
tropism of viruses.
5.5   Future perspectives
Nevertheless, it seems that the development of com-
posite light-responsive carriers consisting of individual 
parts of organic and inorganic nature is the direction of 
future research in the field of nanomedicine. This will 
make it possible to take advantage of each component of 
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the developed smart delivery platform and enable, e.g. 
enhanced loading with drugs, multimodal imaging, tar-
geted properties, prolonged circulation times in blood, 
and so forth. Moreover, the application of light-sensitive 
composite carriers will be able to provide noninvasive 
activation of therapeutics in combination with PTT at the 
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